Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Donini

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Journal of Thoracic Disease|June 29, 2018
Next generation immune-checkpoints for cancer therapyChiara Donini, Lorenzo D'Ambrosio, Giovanni Grignani, et al.
Cells|April 3, 2021
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical PerspectiveChiara Donini, Ramona Rotolo, Alessia Proment, et al.
International Journal of Molecular Sciences|June 20, 2019
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive ImmunotherapyRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Cancers|June 2, 2021
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma ModelsIlenia Iaia, Loretta Gammaitoni, Giulia Cattaneo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 22, 2022
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapyCristina Chiriaco, Chiara Donini, Marco Cortese, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosisFederica Galvagno, Valeria Leuci, Annamaria Massa, et al.
British Journal of Haematology|September 26, 2022
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriersPaola Circosta, Chiara Donini, Susanna Gallo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplificationMarco Cortese, Erica Torchiaro, Alice D'Andrea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translationRaffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Journal of Thoracic Disease|June 29, 2018
Next generation immune-checkpoints for cancer therapyChiara Donini, Lorenzo D'Ambrosio, Giovanni Grignani, et al.
Cells|April 3, 2021
Cellular Immunotherapy Targeting Cancer Stem Cells: Preclinical Evidence and Clinical PerspectiveChiara Donini, Ramona Rotolo, Alessia Proment, et al.
International Journal of Molecular Sciences|June 20, 2019
CAR-Based Strategies beyond T Lymphocytes: Integrative Opportunities for Cancer Adoptive ImmunotherapyRamona Rotolo, Valeria Leuci, Chiara Donini, et al.
Cancers|June 2, 2021
Recruitment, Infiltration, and Cytotoxicity of HLA-Independent Killer Lymphocytes in Three-Dimensional Melanoma ModelsIlenia Iaia, Loretta Gammaitoni, Giulia Cattaneo, et al.
Journal of Experimental & Clinical Cancer Research : CR|October 22, 2022
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapyCristina Chiriaco, Chiara Donini, Marco Cortese, et al.
Cancer Immunology, Immunotherapy : CII|November 2, 2024
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosisFederica Galvagno, Valeria Leuci, Annamaria Massa, et al.
British Journal of Haematology|September 26, 2022
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti-leukaemic potential and alloreactivity across major human leukocyte antigen barriersPaola Circosta, Chiara Donini, Susanna Gallo, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 19, 2024
Preclinical efficacy of a HER2 synNotch/CEA-CAR combinatorial immunotherapy against colorectal cancer with HER2 amplificationMarco Cortese, Erica Torchiaro, Alice D'Andrea, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 14, 2018
BRAF and MEK Inhibitors Increase PD-1-Positive Melanoma Cells Leading to a Potential Lymphocyte-Independent Synergism with Anti-PD-1 AntibodyMartina Sanlorenzo, Igor Vujic, Arianna Floris, et al.
Cancer Immunology, Immunotherapy : CII|September 13, 2025
Development and activity of canine B7-H3-CAR.CIK lymphocytes against sarcomas: preclinical evidence and perspectives for human clinical translationRaffaella De Maria, Chiara Donini, Sonia Capellero, et al.
Pageof 2